Tyawalt 450 mg/g granules for use in drinking water for pigs
Tyawalt 450 mg/g granules for use in drinking water for pigs
Authorised
- Tiamulin hydrogen fumarate
Product identification
Medicine name:
Tyawalt 450 mg/g granules for use in drinking water for pigs
Tyawalt 450 mg/g Granulaat voor gebruik in drinkwater
Tyawalt 450 mg/g Granulés pour administration dans l'eau de boisson
Tyawalt 450 mg/g Granulat zum Eingeben über das Trinkwasser
Active substance:
- Tiamulin hydrogen fumarate
Target species:
-
Pig
Route of administration:
-
In drinking water use
Product details
Active substance and strength:
-
Tiamulin hydrogen fumarate450.00/milligram(s)1.00gram(s)
Pharmaceutical form:
-
Granules for use in drinking water
Withdrawal period by route of administration:
-
In drinking water use
-
Pig
-
Meat and offal2day(8.8 mg tiamulin hydrogen fumarate (equivalent to 19.6 mg of product)/kg body weight).
-
Meat and offal4day(20 mg tiamulin hydrogen fumarate (equivalent to 44.4 mg of product)/kg body weight).
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QJ01XQ01
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Belgium
Package description:
- (ID2) 5 kilogram(s): unspecified outer container with 1 Bag (Low Density PolyEthylene; Aluminium; PolyEthylene TerePhthalate) with 5 kilogram(s)
- (ID1) 1 kilogram(s): unspecified outer container with 1 Bag (Low Density PolyEthylene; Aluminium; PolyEthylene TerePhthalate) with 1 kilogram(s)
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
- KRKA tovarna zdravil d.d. Novo mesto
Marketing authorisation date:
Manufacturing sites for batch release:
- KRKA tovarna zdravil d.d. Novo mesto
- TAD Pharma GmbH
Responsible authority:
- Federal Agency For Medicines And Health Products
Authorisation number:
- BE-V526124
Date of authorisation status change:
Reference member state:
-
Germany
Procedure number:
- DE/V/0264/001
Concerned member states:
-
Belgium
-
Denmark
-
France
-
Netherlands
-
Portugal
-
Spain
-
United Kingdom (Northern Ireland)
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
Package Leaflet
This document does not exist in this language (English). You can find it
in another language below.